Nahia Jean Amoura, MD
Obstetrics/Gynecology · Fresno
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 31 years
- Nebraska College of Medicine, 1995
Offices
1 location · Central California Faculty Medical Group Inc · 256 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Amoura’s office at (559) 443-2694 to ask if they take your plan before you enroll.
California Medical Board record
Licence C197042 · Current
Licensed to practise in California · since 2024 · expires 2028-08-31 · University of Nebraska College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Obstetrics and Gynecology - Obstetrics and Gynecology
Original Medicare doctor bills
$2,388
Medicare paid this office $2,388 for 13 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Who their Medicare patients are
13 Original Medicare patients in 2024. Average age 58 · 85 and older 0% · Health risk score 1.24. Above the middle of the specialty; the typical obstetrics & gynecology clinician is at 0.88.
The office billed $6,980, Medicare allowed $3,088 and paid $2,388; for 15 services of 4 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 13 | 15 | 58 | 1.24 | $6,980 | $2,388 |
| 2023 | 21 | 32 | 59 | 1.25 | $9,901 | $2,480 |
| 2022 | 15 | 21 | 55 | 1.04 | $9,825 | $3,094 |
| 2021 | 20 | 30 | 56 | 2.21 | $10,738 | $3,369 |
| 2020 | 16 | 24 | 49 | 1.42 | $5,900 | $1,655 |
| 2019 | 16 | 26 | 42 | 0.74 | $10,027 | $3,406 |
| 2018 | 16 | 18 | 54 | 1.31 | $3,590 | $846 |
| 2016 | 13 | 171 | 45 | 0.87 | $4,785 | $1,229 |
| 2015 | 22 | 183 | 51 | 1.39 | $6,363 | $1,910 |
| 2014 | 27 | 54 | 58 | 0.84 | $20,481 | $3,455 |
| 2013 | 24 | 669 | 51 | 1.54 | $22,527 | $5,689 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2021: 1 service
| Short return visit (20+ min) | 11 | $532 | $38 |
Medicaid work
$17,975 in 2024
Medicaid paid $17,975 for 58 billed services this clinician did in 2024, up to 32 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 46 | $17,586 |
| Short return visit (20+ min) | 12 | $389 |
| 2024 | 58 | 2 | 32 | $17,975 |
| 2023 | 185 | 5 | 16 | $5,502 |
| 2022 | 163 | 3 | 15 | $7,528 |
| 2021 | 86 | 1 | 15 | $2,985 |
| 2020 | 59 | 1 | 17 | $1,856 |
| 2018 | 27 | 1 | 14 | $1,082 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 60 | $2,971 |
| Return visit (30+ min) | 27 | $1,592 |
| Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 17 | $639 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 47 | $160 |
| Hospital outpatient clinic visit for assessment and management of a patient | 34 | $139 |
2022
| Return visit (30+ min) | 79 | $4,391 |
| Short return visit (20+ min) | 70 | $2,631 |
| Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 14 | $506 |
2021
| Short return visit (20+ min) | 86 | $2,985 |
2020
| Short return visit (20+ min) | 59 | $1,856 |
2018
| Short return visit (20+ min) | 27 | $1,082 |
Drugs they prescribed that Part D paid
$19,982
Pharmacies billed $19,982 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 221) in 2024. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0%.
207 generic and 14 brand-name prescriptions · $19,982 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Estradiol (Twice Weekly) | 17 | $3,125 | $184 |
| Estradiol Valerate | 17 | $1,659 | $98 |
| Progesterone | 34 | $1,497 | $44 |
| Estradiol | 26 | $848 | $33 |
| Spironolactone | 38 | $726 | $19 |
See all 7 drugs
| Estradiol (Twice Weekly) | 17 | $3,125 | $184 |
| Estradiol Valerate | 17 | $1,659 | $98 |
| Progesterone | 34 | $1,497 | $44 |
| Estradiol | 26 | $848 | $33 |
| Spironolactone | 38 | $726 | $19 |
| Finasteride | 33 | $385 | $12 |
| Oxybutynin Chloride Er | 14 | $206 | $15 |
Year by year
| 2024 | 221 | 31 | 0% (0) | 6% | $19,982 |
| 2023 | 224 | 29 | 0% (0) | 7% | $21,393 |
| 2022 | 225 | 30 | 0% (0) | 10% | $21,428 |
| 2021 | 212 | 32 | 0% (0) | None | $14,928 |
| 2020 | 184 | 17 | None | 12% | $12,463 |
| 2019 | 142 | 18 | None | 9% | $9,109 |
| 2018 | 51 | 12 | 0% (0) | None | $1,643 |
| 2017 | 50 | None | 0% (0) | 36% | $2,511 |
| 2016 | 76 | None | None | 17% | $3,542 |
| 2015 | 47 | 12 | 0% (0) | 45% | $4,284 |
| 2014 | 29 | 11 | 0% (0) | 48% | $2,582 |
| 2013 | 44 | 14 | None | 25% | $4,778 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Estradiol (Twice Weekly) | 14 | $4,622 | $330 |
| Estradiol Valerate | 16 | $2,453 | $153 |
| Spironolactone | 34 | $1,631 | $48 |
| Progesterone | 34 | $1,464 | $43 |
| Estradiol | 33 | $898 | $27 |
| Dotti | 12 | $819 | $68 |
| Finasteride | 31 | $576 | $19 |
| Testosterone Cypionate | 12 | $551 | $46 |
2022: 6 drugs
| Estradiol (Twice Weekly) | 26 | $6,532 | $251 |
| Estradiol | 42 | $1,888 | $45 |
| Spironolactone | 40 | $1,713 | $43 |
| Dotti | 12 | $1,025 | $85 |
| Progesterone | 18 | $590 | $33 |
| Finasteride | 22 | $263 | $12 |
2021: 7 drugs
| Estradiol (Twice Weekly) | 25 | $4,904 | $196 |
| Estradiol | 39 | $1,722 | $44 |
| Spironolactone | 25 | $1,359 | $54 |
| Progesterone | 20 | $1,057 | $53 |
| Estradiol (Once Weekly) | 11 | $1,002 | $91 |
| Testosterone Cypionate | 13 | $865 | $67 |
| Finasteride | 33 | $592 | $18 |
2020: 6 drugs
| Estradiol (Once Weekly) | 25 | $3,597 | $144 |
| Estradiol (Twice Weekly) | 23 | $3,167 | $138 |
| Spironolactone | 18 | $1,690 | $94 |
| Progesterone | 17 | $1,104 | $65 |
| Estradiol | 30 | $562 | $19 |
| Finasteride | 33 | $526 | $16 |
2019: 3 drugs
| Estradiol | 46 | $5,231 | $114 |
| Progesterone | 19 | $1,251 | $66 |
| Finasteride | 28 | $345 | $12 |
2018: 1 drug
| Estradiol | 15 | $567 | $38 |
2017: 2 drugs
| Estradiol | 24 | $832 | $35 |
| Medroxyprogesterone Acetate | 11 | $73 | $7 |
2016: 2 drugs
| Estradiol | 30 | $576 | $19 |
| Medroxyprogesterone Acetate | 19 | $78 | $4 |
2015: 1 drug
| Prempro | 18 | $3,436 | $191 |
Professional record
- NPI
- 1891752606
- Licence
- CA C197042, NE 21172California C197042: Current · expires 2028-08-31
- Trained
- Nebraska College of Medicine, 1995 · 31 years ago
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Medicaid ID
- NE 47078557540
- Taxonomy
- Federal specialty code 207V00000X (207V00000X)
- Mailing address
- 2625 E Divisadero St, Fresno, CA, 93721
- NPI first listed
- 2006-04-26
- NPI last updated
- 2024-09-26
- NPI record certified
- 2024-09-26
This is when the NPI record was last certified, not a medical board exam.